STUDY DESIGN: A population-based cohort analysis including deliveries between the years 1991 to 2014 in a tertiary referral hospital was conducted. Incidence of hospitalizations (up to age 18 years) due to various neurological conditions was compared between offspring of both groups. Kaplan-Meyer curve was used to assess cumulative hospitalization incidence. Cox proportional hazards model was used to control for baseline selected confounders. RESULTS: During the study period 206,731 deliveries met the inclusion criteria. Of those, 0.2% (n¼343) were complicated by shoulder dystocia. In most of the investigated neurological conditions, including the risk for cerebral palsy, no significant differences were found between offspring of both groups (Table) . Similarly, Kaplan-Meyer survival curve revealed comparable rates of cumulative neurological-related hospitalization in both groups (log rank p-value¼0.342; Figure) . Using a Cox proportional hazards model to control for gestational age, shoulder dystocia did not appear to be independently associated with total neurological hospitalization (adjusted HR ¼ 0.73; 95% CI 0.36-1.47; p¼0.381).
OBJECTIVE: Hypertensive disease in pregnancy is associated with substantial maternal and neonatal morbidity. The pathogenesis of preeclampsia is a complex process involving immunological and genetic factors, some of which are implicated in the development of endocrine disease. In direct extrapolation, we sought to ascertain whether preeclampsia is an independent risk factor for longterm endocrine disease in the exposed offspring. STUDY DESIGN: A population based cohort analysis comparing the longterm risk of endocrine morbidity of children born to mothers with and without preeclampsia was conducted. Endocrine morbidity included hospitalizations involving a predefined set of ICD9 codes, as recorded in the hospital records. Deliveries occurred between 1991-2014 in a tertiary medical center. Mothers with chronic hyertensive disease, and children with congenital malformations were excluded from the study. A Kaplan-Meier survival curve was constructed to compare cumulative endocrine morbidity. A Cox proportional hazards model was used to control for time to event. A generalized estimated equation model was used to control for maternal clusters. RESULTS: During the study period 253,808 patients met the inclusion criteria; 7,660 patients had mild preeclampsia (3.0%), 2,366 had severe preeclampsia (0.9%) and 81 had eclampsia (0.01%). Offspring of patients with preeclampsia had significantly higher rates of endocrine hospitalizations compared to those born to unexposed women (07% vs 0.4%;p ¼ 0.001). A significant linear association was noted between the severity of preeclampsia and endocrine hospitalizations (0.7% in mild vs. 1.4% in severe preeclampsia p¼0.002 using the x2 test for trends; Table) . Specifically, obesity was more common amongst offspring of exposed women with a statistically significant linear association to the severity of preeclampsia (0.2% for unexposed mothers, 0.4% for mild preeclampsia, 0.3% for severe preeclampsia and 1.4% for eclampsia, p <0.001). While controlling for gestational and maternal age using a Cox model, mild preeclampsia was found to be an independent risk factor for endocrine morbidity (adjusted HR¼1.5, 95% CI 1.1-1.9; p¼0.01). Using a generalized estimated equation model the exposed offspring had significantly higher incidence of endocrine morbidity (OR 1.4 95% CI 1.1-1.8 p¼0.006). CONCLUSION: Preeclampsia in an independent risk factor for longterm endocrine disease of the offspring, specifically obesity.
793 Obstetric and neonatal outcomes in prolonged pregnancies at or beyond 42 weeks' gestation. OBJECTIVE: A Cochrane review on labor induction concludes that induction at or beyond term compared with expectant management is associated with fewer perinatal deaths and fewer cesarean sections (CS). The optimal timing of induction has yet to be determined; our experience is that spontaneous onset of labor is associated with a lower CS rate at all gestational ages. With that in mind we sought to examine both obstetric intervention rates and rates of perinatal mortality and morbidity in pregnancies that reach 42 weeks' gestation. STUDY DESIGN: A review of all cases of prolonged pregnancies defined as 42 weeks' gestation over a 10 year period from 2007 to 2016 was performed. All demographic and delivery details were entered prospectively into a computerized database; these data are subject to continuous audit. At our institution pregnancies reaching 41 weeks+5 days undergo a formal ultrasound for biophysical profile; once reassuring induction is offered at 42 weeks' gestation. All spontaneous labors are managed in a standardized fashion according to active management of labor principles. We examined the incidence and outcome of prolonged pregnancies and compared them to the background institutional rate. Specific details, including radiology reports and placental pathology where available, were gathered for all cases of perinatal mortality, neonatal encephalopathy (NE) and hypoxic ischemic encephalopathy (HIE). RESULTS: Over the study period 90,564 mothers delivered infants weighing 500g. 4791 pregnancies reached 42 weeks' , an incidence of 4.8%. Of these, 87.7% underwent induction of labor, 2.4% had a pre-labour CS and 9.9% labored spontaneously. Labor and delivery details are inTable 1. The overall CS rate was 25.9% compared to 22.1% (p<0.0001, 95% CI 3.7-3.9). The CS rate in nulliparous women 42 weeks was 33% compared to 24.1% (p<0.0001, 95% CI 8.8-8.9). There were 10 perinatal mortalities in the group, an uncorrected perinatal mortality rate (PNMR) of 1.89 +-2.29. The institutional uncorrected PNMR during that period was 6.93 +-1.25 (p<0.0001, 95% CI -5.07-5.07). Of these 10 cases, 8 had a congenital abnormality. There were 16 cases of HIE/NE; a detailed breakdown of these is contained in Table 2 . CONCLUSION: Pregnancies that reach 42 weeks have a CS rate of 33% but a low perinatal mortality and morbidity rate. The CS rate remained lower for women who spontaneously labored even at 42 weeks' gestation, supporting our policy of expectant management to control CS rates.
